Searchable abstracts of presentations at key conferences in endocrinology

ea0011p468 | Endocrine tumours and neoplasia | ECE2006

Short-term evaluation of quality of life in acromegalic patients

Sardella C , Cosci C , Gavioli S , Bogazzi F , Martino E

Active acromegaly is associated with significant comorbidity and reduced quality of life. Cross-sectional studies have shown that quality of life did not significantly change in long-term cured acromegalic patients. However, the effect of medical treatment on the quality of life in the short term is unknown.We evaluated the quality of life by a disease-specific questionnaire in a longitudinal study before and after a 6-month course with somatostatin anal...

ea0011p708 | Reproduction | ECE2006

Androgenic status is influenced by AR polymorphism (CAG repeats number)

Canale D , Caglieresi C , Moschini C , Macchia E , Martino E

Exon 1 of AR gene contains a variable number of CAG triplets, which encode a polyglutamine stretch of variable length in the N-terminal domain of the receptor. Experimental evidence has accumulated in demonstrating that the length of this stretch influences AR transcriptional activity and therefore modulates target organs responsiveness to androgens. Aim of our study was to evaluate CAG repeats length [(CAGr)n] in various conditions hypothetically influenced by AR function. 35...

ea0011p849 | Thyroid | ECE2006

The efficacy of levothyroxine therapy in the nontoxic multinodular goiter

Mihai AM , Ranetti AE , Spiroiu C , Mazilu A , Ranetti C

There is no ideal treatment for the simple goiter. The treatment options in NMG is: surgery, I131, L-thyroxine or continous monitoring without therapy.From 2000–2003 we evaluated 150 patients (120 women and 30 men) having their agings between 20 and 80 years with L-T4 treatment for nontoxic multinodular goiter. Duration of therapy was 3 years. The pacients was evaluated by clinical examination, level of TSH, free-T4,...

ea0010p53 | Pituitary | SFE2005

Is screening for colonic cancer in acromegaly fruitful?

Wujanto C , Jayasena C , Banerjee A , Meeran K , Todd J

Background: Controversy exists over the prevalence of colonic neoplasia in individuals with acromegaly. Some previous studies have demonstrated an increased prevalence of colorectal neoplasia compared to controls, however others have shown no such association. Furthermore, colonoscopy in acromegalic individuals has an increased rate of complications and even death....

ea0010p54 | Pituitary | SFE2005

Long-term review of 21 acromegalic patients with yttrium-90 implants

Jayasena C , Wujanto C , Todd J , Meeran K

Background: Yttrium-90 (90Y) pituitary implants have previously been used to treat patients with growth hormone (GH) secreting pituitary adenoma. This study reports the long-term effect of 90Y implants on growth hormone levels and pituitary function in a group of acromegalic patients....

ea0010p55 | Pituitary | SFE2005

Challenges of colonoscopy in patients with acromegaly

Wujanto C , Jayasena C , Todd J , Meeran K

BackgroundPrevious studies suggest that patients with acromegaly should have regular colonoscopic examinations due to their increased risk of colorectal neoplasia. However, acromegalic patients have significantly enlarged colon and increased rate of complications due to colonoscopy have been reported.AimTo assess the difficulty of performing colonoscopy in acromegalic patients by comparing large bowel length,...

ea0009p151 | Thyroid | BES2005

Psychometric validation of new measures of hypothyroid-dependent quality of life (QoL) and symptoms

McMillan C , Bradley C , Razvi S , Weaver J

Objective: To evaluate the psychometric properties of two new condition-specific questionnaires: (1) the 18-item ThyDQoL, an individualised patient-centred measure of perceived impact of hypothyroidism on QoL, and (2) the 15-item ThySC symptom checklist in which patients provide 'bother' ratings for common hypothyroid symptoms.Method: A cross-sectional survey was conducted with 110 adults with clinical or subclinical hypothyroidism [mean age: 55.1 plus/m...

ea0005p129 | Endocrine Tumours and Neoplasia | BES2003

Stable iodide and radioiodide transport in extrathyroidal tissues

Clarke C , Brennan C , Rodgers K , Dwyer R , Smyth P

The demonstration in extrathyroidal tissues of the sodium iodide symporter (NIS) has raised the possibility that 131I, commonly used as a therapeutic ablative agent in hyperthyroidism and thyroid cancer, might be applied in the treatment of tumours in other NIS expressing tissues such as human breast cancer. As thyroidal uptake of 131I is known to be inversely proportional to circulating stable I- concentration, the aim of this study was to determine how I- would effect such u...

ea0005p136 | Endocrine Tumours and Neoplasia | BES2003

Methylation status and iodide uptake

Brennan C , Dwyer R , Clarke C , Smyth P

Expression of the Sodium Iodide symporter (NIS) in the breast was thought to be restricted to lactation but recently have been shown in breast cancer and benign breast disease. CpG island methylation of the promoter region of NIS is known to decrease iodide uptake in the thyroid. No such information has been documented in the breast. The aim of this study was to investigate the effect of demethylating agents on iodide uptake in breast cancer cell lines MCF-7 (oestrogen (E) and...

ea0003oc29 | Metabolism | BES2002

Deleterious effect of non-esterified free fatty acids (NEFAs) on resistance artery endothelial function

Sainsbury C , Hillier C , Sattar N , Petrie J , Connell J

Elevated circulating concentrations of non-esterified free fatty acids (NEFAs) are observed in states of insulin resistance and may be associated with increased cardiovascular risk. We hypothesised that NEFAs directly impair endothelial NO bioavailability via increased oxidative stress, in addition to their proposed indirect effect via VLDL. The study was designed to investigate the effect of monounsaturated and saturated fatty acids on endothelium-dependent and -independent v...